abs148.txt	t-cell	responses	to	minor	histocompatibility	antigens	(mhas)	mediate	bothantitumor	immunity	(graft-versus-leukemia	[gvl])	and	graft-versus-host	disease(gvhd)	in	allogeneic	stem	cell	transplant		identifying	mhas	with	high	allelefrequency		tight	binding	affinity	to	common	hla	molecules		and	narrow	tissuerestriction	could	enhance	immunotherapy	against	leukemia		genotyping	and	hlaallele	data	from	101	hla-matched	donor-recipient	pairs	(drps)	werecomputationally	analyzed	to	predict	both	class	i	and	class	ii	mhas	likely	toinduce	either	gvl	or	gvhd		roughly	twice	as	many	mhas	were	predicted	inhla-matched	unrelated	donor	(mud)	stem	cell	transplantation	(sct)	compared	withhla-matched	related	transplants		an	expected	result	given	greater	geneticdisparity	in	mud	sct		computational	analysis	predicted	14	of	18	previouslyidentified	mhas		with	2	minor	antigen	mismatches	not	being	contained	in	thepatient	cohort		1	missed	mha	resulting	from	a	noncanonical	translation	of	thepeptide	antigen		and	1	case	of	poor	binding	prediction		a	predicted	peptideepitope	derived	from	grk4		a	protein	expressed	in	acute	myeloid	leukemia	andtestis		was	confirmed	by	targeted	differential	ion	mobility	spectrometry-tandemmass	spectrometry		t	cells	specific	to	unc-grk4-v	were	identified	by	tetrameranalysis	both	in	drps	where	a	minor	antigen	mismatch	was	predicted	and	in	drpswhere	the	donor	contained	the	allele	encoding	unc-grk4-v		suggesting	that	thisantigen	could	be	both	an	mha	and	a	cancer-testis	antigen		computational	analysisof	genomic	and	transcriptomic	data	can	reliably	predict	leukemia-associated	mhaand	can	be	used	to	guide	targeted	mha	discovery	
